![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
| Item Type: | Article |
|---|---|
| Title: | Total and high-molecular-weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition study |
| Creators Name: | Aleksandrova, K. and Boeing, H. and Jenab, M. and Bueno-de-Mesquita, H.B. and Jansen, E. and van Duijnhoven, F.J. and Fedirko, V. and Rinaldi, S. and Romieu, I. and Riboli, E. and Romaguera, D. and Westphal, S. and Overvad, K. and Tjonneland, A. and Boutron-Ruault, M.C. and Clavel-Chapelon, F. and Kaaks, R. and Lukanova, A. and Trichopoulou, A. and Lagiou, P. and Trichopoulos, D. and Agnoli, C. and Mattiello, A. and Saieva, C. and Vineis, P. and Tumino, R. and Peeters, P.H. and Argueelles, M. and Bonet, C. and Sanchez, M.J. and Dorronsoro, M. and Huerta, J.M. and Barricarte, A. and Palmqvist, R. and Hallmans, G. and Khaw, K.T. and Wareham, N. and Allen, N.E. and Crowe, F.L. and Pischon, T. |
| Abstract: | Adiponectin - an adipose-tissue-derived protein may provide a molecular link between obesity and colorectal cancer (CRC), but evidence from large prospective studies is limited. In particular, no epidemiological study explored high-molecular-weight (HMW) and non-HMW adiponectin fractions in relation to CRC risk, despite they were hypothesised to have differential biological activities, i.e. regulating insulin sensitivity (HMW-adiponectin) versus inflammatory response (non-HMW-adiponectin). In a prospective nested case-control study we investigated whether pre-diagnostic serum concentrations of total, HMW and non-HMW-adiponectin are associated with risk of CRC, independent of obesity and other known CRC risk factors. A total of 1206 incident cases (755 colon, 451 rectal) were matched to 1206 controls using incidence density sampling. In conditional logistic regression, adjusted for dietary and lifestyle factors, total adiponectin and non-HMW-adiponectin concentrations were inversely associated with risk of CRC [relative risk (RR) comparing highest versus lowest quintile = 0.71, 95% confidence interval (CI) = 0.53-0.95, P (trend)=0.03 for total adiponectin and 0.45, 95%CI=0.34-0.61, P (trend)<0.0001 for non-HMW-adiponectin]. HMW-adiponectin concentrations were not associated with CRC risk (RR=0.91, 95%CI=0.68-1.22, P (trend)=0.55). Non-HMW-adiponectin was associated with CRC risk even after adjustment for body mass index and waist circumference (RR=0.39, 95%CI=0.26-0.60, P (trend)<0.0001); whereas the association with total adiponectin was no longer significant (RR=0.81, 95%CI=0.60-1.09, P (trend)=0.23). When stratified by cancer site, non-HMW-adiponectin was inversely associated with both colon and rectal cancer. These findings suggest an important role of the relative proportion of non-HMW-adiponectin in CRC pathogenesis. Future studies are warranted to confirm these results and to elucidate the underlying mechanisms. |
| Keywords: | Total Adiponectin, High-Molecular Weight (HMW) Adiponectin, Non-HMW Adiponectin |
| Source: | Carcinogenesis |
| ISSN: | 0143-3334 |
| Publisher: | Oxford University Press |
| Volume: | 33 |
| Number: | 6 |
| Page Range: | 1211-1218 |
| Date: | November 2012 |
| Official Publication: | https://doi.org/10.1093/carcin/bgs133 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
